Clinical Trial

A Comparative Study Between Rectal and Intrauterine Misoprostol Administration in the Reduction of Blood Loss During and After Elective Cesarean Delivery in Low Risk Women

Completed
View on ClinicalTrials.gov →
Summary
One hundred forty low risk pregnant women scheduled for elective cesarean delivery were randomized (1:1) into two groups: the intrauterine group (n=70) received 400 μg misoprostol (200 μg at each uterine cornu) after placental delivery, while the rectal group (n=70) received 400 μg misoprostol rectally via urinary catheter insertion preoperatively.
Trial Details
NCT Number NCT07728084
Lead Sponsor Cairo University
Conditions Postpartum Hemorrhage, Cesarean Section
Enrollment 140 participants
Start Date 2025-01-13
Primary Completion 2026-04-25 (estimated)
Study Completion 2026-06-29 (estimated)
Updated on ClinicalTrials.gov 2026-07-27